The Long Run with Luke Timmerman
En podkast av Timmerman Report
173 Episoder
-
Ep175: Andy Scharenberg on in vivo CAR-T cell therapies
Publisert: 16.3.2025 -
Ep174: Najat Khan on the TechBio Movement
Publisert: 3.3.2025 -
Ep173: Robert Blum on Building a Fully Integrated Biopharma For Muscle Disorders
Publisert: 11.2.2025 -
Ep172: Mostafa Ronaghi on Studying Live Cells at Scale
Publisert: 27.1.2025 -
Ep171: Ram Aiyar on RNA Editing Medicines
Publisert: 13.1.2025 -
Ep170: David Schenkein on Investing in the Future of Biotech
Publisert: 2.1.2025 -
Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines
Publisert: 11.12.2024 -
Ep168: Jonathan Bricker on How to Quit Smoking & Prevent Cancer
Publisert: 25.11.2024 -
Ep167: Leslie Williams on transfer RNA therapies
Publisert: 6.11.2024 -
Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity
Publisert: 15.10.2024 -
Ep165: Zach Hornby on Tackling Cancer Drug Resistance
Publisert: 26.9.2024 -
Ep164: Ted Love and Alan Anderson on Raising the Bar for Sickle Cell Disease Patients
Publisert: 5.9.2024 -
Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases
Publisert: 14.8.2024 -
Ep162: Sean McClain on AI for Biologic Drug Discovery
Publisert: 16.7.2024 -
Ep161: Jeff Stein on a Long-Lasting Flu Drug
Publisert: 1.7.2024 -
Ep160: Abe Ceesay on Precision Neuroscience
Publisert: 17.6.2024 -
Ep159: Jimi Olaghere on Being Functionally Cured of Sickle Cell Disease
Publisert: 3.6.2024 -
Ep158: David Younger and Randolph Lopez on SynBio & AI for Discovery
Publisert: 20.5.2024 -
Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery
Publisert: 1.5.2024 -
Ep156: David Liu on New Tools and Techniques for Biology
Publisert: 16.4.2024
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
